Drugs & TargetsFree FDA accepts Celyad IND application for CYAD-101, a non-gene edited allogeneic CAR-T candidate July 27, 2018Vol.44 No.30
Drugs & TargetsFree BMS, Tsinghua University to develop therapies for autoimmune diseases, cancer July 27, 2018Vol.44 No.30
Clinical RoundupFree UCLA’s Yang receives $1.4M to develop cellular therapy using blood stem cells July 27, 2018Vol.44 No.30
FreeIn Brief Manotti named senior vice president, chief development officer at MSKCC July 27, 2018Vol.44 No.30
